ProQR Therapeutics (PRQR) Cash from Operations (QoQ) (2013 - 2026)
ProQR Therapeutics (PRQR) Cash from Operations (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.34% |
| Dec 31, 2025 | -23.85% |
| Sep 30, 2025 | -2.40% |
| Jun 30, 2025 | 27.04% |
| Mar 31, 2025 | -36.17% |
| Dec 31, 2024 | -112.59% |
| Sep 30, 2024 | 17.72% |
| Jun 30, 2024 | 54.57% |
| Mar 31, 2024 | -323.63% |
| Dec 31, 2023 | 57.44% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | -124.77% |
| Mar 31, 2023 | 349.79% |
| Dec 31, 2022 | -16.07% |
| Sep 30, 2022 | -3.50% |
| Jun 30, 2022 | 27.47% |
| Mar 31, 2022 | -571.37% |
| Dec 31, 2021 | 153.89% |
| Sep 30, 2021 | 19.26% |
| Jun 30, 2021 | 15.15% |